|
⚲
|
| Tetraphase Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001373707 |
| Sale | 2009-09-11 ($29.6 M Offered, $10.0 M Sold) |
| Fund | |
| Phone | 6177153600 |
| Address | 480 Arsenal Street Watertown, 02472 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Robert Weisskoff | |
| Guy Macdonald | |
| Lawrence Miller | |
| Karl Handelsman | |
| David Lubner | |
| Eric Gordon | |
| Douglas Cole |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Ampersand Partners LLC
✚
|
0.0 | |
|
Ampfield Holdings Offshore H Ltd
✚
|
0.0 | |
|
A-MPG-14-Fund, a series of AngelList-JM-Funds, LLC
✚
|
0.0 | |
|
Amphibian ETH Alpha Fund, LP
✚
|
0.0 | |
|
Amplifi Investors, LLC
✚
|
0.0 | |
|
AMP Special Opportunity Fund I, LLC
✚
|
0.0 | |
|
AMR Co-Investment LLC
✚
|
0.0 | |
|
AMR-DirecPath, L.P.
✚
|
0.0 | |
|
Amryt Pharma plc
✚
|
0.0 | |
|
AMEC International Investments B.V.
✚
|
0.0 |